Bladder Cancer Research | Understanding Bench-to-Bedside

June 19, 2015
by Stephanie Chisolm

Research can lead to improved survival. It can find ways to help patients have a better quality of life. Ways to diagnose and treat bladder cancer today are a result of many years of slow and steady scientific discovery. Do you ever wonder how the research that happens in a laboratory makes its way to bladder cancer patients? The term “bench-to-bedside” describes how the results of research are used to develop new ways to treat patients. It is also known as translational medicine. It “translates” scientific findings into the tools your doctor can use. Once something shows promise in a…

Read More...

National Bladder Cancer Awareness Month Recognized

May 22, 2015
by Monica Smith

Thank you to Senator Menendez (D-NJ) with co-sponsors Senator Isakson (R-GA) and Senator Brian Schatz (D-HI), for introducing and passing SRES 187 to recognize May as National Bladder Cancer Awareness Month in the Senate.

Read More...

New Bladder Cancer Journal Launches First Issue

May 20, 2015
by Monica Smith

Recognizing this unmet need, Seth Lerner and Dan Theodorescu convened a first-class Editorial Board and partnered with IOS Press to create Bladder Cancer, an international journal devoted solely to the study of bladder cancer (ISSN: 2352-3727).

Read More...

Interning with a Passion

May 18, 2015
by Nadine Rotundo

The first encounter I had with bladder cancer was in October of 2011. I was a senior in high school and I was preoccupied with varsity sports, starting the college application process, and hanging out with my friends. It was the Friday of my high school’s homecoming weekend and I had plans to go over at a friend’s house after school to make t-shirts that spelled out “GO TEAM!” to wear at the upcoming football game on Saturday

Read More...

BCG Update

March 24, 2015
by Monica Smith

Since August, many patients have been experiencing a delay in treatment due to the production of TICE BCG. There has been increased worldwide demand for the drug and few manufacturers causing a backorder issue. Generally, there has been a delay in orders between 2 – 8 weeks which impacts patients, physicians and the entire bladder cancer community.

Read More...

Advocacy Issue – Blue Light Cystoscopy

March 3, 2015
by Monica Smith

You may have read our posting with an update on the issue regarding reimbursement of blue light cystoscopy. As all of you know, there are very few treatments and innovations for bladder cancer. It is BCAN’s position that everyone should have equal access to all treatments, tests and innovations that have been approved by the FDA.

Read More...

Moving Towards Improved Patient-Centered Research:  Perspective from a John Quale Travel Fellow

February 24, 2015
by Ken Nepple, MD

As an early investigator trying to have an impact in bladder cancer, I received a John Quale Travel Fellowship to attend the 2011 BCAN Think Tank Meeting. This award has honestly had a profound impact on my personal understanding of bladder cancer and also provided me with the opportunity to advance my career. For me, this impact has been best personified by two concepts: 1. Ask important questions and 2. Work with smart and motivated people.

Read More...
GO TO TOP ^
This website is supported by a generous grant from Photocure
SITE DESIGN: GALANTI DESIGN